Idioma:

The efficacy and safety of dipyrone (Novalgin) tablets in the treatment of acute migraine attacks: a double-blind, cross-over, randomized, placebo-controlled, multi-center study

Tulunay, F Cankat ; Ergün, Hakan ; Gülmez, Sinem Ezgi ; Ozbenli, Taner ; Ozmenoğlu, Mehmet ; Boz, Cavit ; Erdemoglu, Ali Kemal ; Varlikbas, Adnan ; Göksan, Baki ; Inan, Levent

Functional neurology, 2004-07, Vol.19 (3), p.197-202 [Periódico revisado por pares]

Italy

Sem texto completo

Citações Citado por

Enviar para

Título:
The efficacy and safety of dipyrone (Novalgin) tablets in the treatment of acute migraine attacks: a double-blind, cross-over, randomized, placebo-controlled, multi-center study
Autor: Tulunay, F Cankat ; Ergün, Hakan ; Gülmez, Sinem Ezgi ; Ozbenli, Taner ; Ozmenoğlu, Mehmet ; Boz, Cavit ; Erdemoglu, Ali Kemal ; Varlikbas, Adnan ; Göksan, Baki ; Inan, Levent
Assuntos: Adolescent ; Adult ; Aged ; Analgesics - therapeutic use ; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use ; Chi-Square Distribution ; Cross-Over Studies ; Dipyrone - therapeutic use ; Double-Blind Method ; Female ; Humans ; Male ; Middle Aged ; Migraine with Aura - complications ; Migraine with Aura - drug therapy ; Migraine without Aura - complications ; Migraine without Aura - drug therapy ; Pain Measurement ; Severity of Illness Index
É parte de: Functional neurology, 2004-07, Vol.19 (3), p.197-202
Notas: ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
ObjectType-News-3
content type line 23
Descrição: Dipyrone, an effective analgesic drug, is widely used in the management of headache. However, few studies have evaluated its efficacy and safety in migraine. We aimed to assess the efficacy and safety of 1 g dipyrone (Novalgin, two 500 mg tablets) on pain and related symptoms in acute migraine attacks with or without aura in a double-blind, cross-over, randomized, placebo-controlled, multi-center study design. Seventy-three migraine with or without aura patients, diagnosed according to the IHS criteria, were randomized to receive dipyrone (for 2 attacks) and placebo (for 1 attack). Pain intensity was measured on a four-point verbal pain scale before and 1, 2, 4 and 24 hours after drug intake. Significant improvement of pain was achieved with dipyrone compared to placebo at all time points measured. Both patient and physician evaluations were significantly in favor of dipyrone. Side effects were few and trivial in both groups. We conclude that dipyrone is an effective, safe and cost-effective option in acute migraine management.
Editor: Italy
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

The efficacy and safety of dipyrone (Novalgin) tablets in the treatment of acute migraine attacks: a double-blind, cross-over, randomized, placebo-controlled, multi-center study

Tulunay, F Cankat ; Ergün, Hakan ; Gülmez, Sinem Ezgi ; Ozbenli, Taner ; Ozmenoğlu, Mehmet ; Boz, Cavit ; Erdemoglu, Ali Kemal ; Varlikbas, Adnan ; Göksan, Baki ; Inan, Levent

Italy

Buscando em bases de dados remotas. Favor aguardar.